Nitric oxide induction of IRE1-alpha-dependent CREB phosphorylation in human glioma cells

Yeon Hyang Kim1, Han Seung Joo, Doo-Sik Kim

  • 1Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, Republic of Korea. yeonhkim@yonsei.ac.kr

Insights

Nitric oxide (NO) triggers endoplasmic reticulum (ER) stress and cell death in glioma cells by activating the IRE1-alpha/TRAF2/JNK pathway. This NO-induced pathway leads to CREB phosphorylation, contributing to glioma cell death.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Neuro-oncology

Background:

  • Endoplasmic reticulum (ER) stress is implicated in various cell death pathways.
  • Nitric oxide (NO) plays diverse roles in cellular signaling and physiology.
  • Glioma is a primary brain tumor with significant unmet therapeutic needs.

Purpose of the Study:

  • To investigate the role of nitric oxide (NO) in ER-related cell death in human glioma cells.
  • To elucidate the molecular mechanisms by which NO influences ER stress and cell viability.
  • To identify potential therapeutic targets within the NO-mediated signaling cascade.

Main Methods:

  • Human glioma cell lines (CRT-MG, U87MG) and normal astrocytes were used.
  • Cells were treated with NO donors (SNAP) and ER stress inducers (thapsigargin).
  • Molecular analyses included Western blotting, siRNA knockdown, and assessment of calcium levels and apoptosis.

Main Results:

  • NO donors and ER stress inducers increased cytosolic Ca(2+) and apoptosis in glioma cells.
  • NO activated the ER-associated IRE1-alpha/TRAF2/JNK pathway, leading to CREB phosphorylation.
  • Upregulation of IRE1-alpha and phospho-CREB was observed in glioma cells compared to astrocytes.
  • Interleukin-1beta also induced NO-associated cell death, increasing IRE1-alpha and p-CREB levels.

Conclusions:

  • Intracellular NO modulates the IRE1-alpha-dependent CREB phosphorylation pathway in human glioma cells.
  • The IRE1-alpha-dependent phospho-CREB signaling pathway, responsive to NO/Ca(2+), is crucial for ER-related cell death in glioma.
  • Targeting this pathway may offer a novel therapeutic strategy for glioma treatment.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...